[MOH] Molina Healthcare Thesis 2026: Medicaid Contract Wins Anchor Managed Care Cycle

Key Takeaways

• FY2025 revenue ~$40-42B (+5-7% YoY) with adj. EPS ~$22.00-23.00 — Molina Healthcare Inc. is a large US managed care organization specializing in Medicaid + Medicare + Marketplace plans. FY2025 reflects continued Medicaid managed care contract wins + selected Medicare growth + selected Marketplace expansion partially offset by selected redetermination cycle volume normalization (post-COVID Medicaid eligibility redetermination compressed Medicaid membership growth FY2023-2025).
• 3 segments: Medicaid ~70% + Medicare ~20% + Marketplace ~10% — Medicaid (largest segment) includes selected state Medicaid contracts across ~22 states; Medicare includes selected Medicare Advantage plans; Marketplace includes selected ACA Marketplace plans. ~5.5M+ members served (vs ~5M+ FY2022 pre-redetermination compression).
• CEO Joseph Zubretsky since November 2017 — Zubretsky's CEO tenure has executed transformational margin recovery + selected operational discipline + selected aggressive contract win strategy. Zubretsky background: ex-The Hanover Insurance Group CEO + ex-Aetna Senior Vice President + ~25-year insurance/managed care executive career. Zubretsky's tenure has executed: continued Medicaid contract wins (selected RFP wins 2018-2024 for selected state Medicaid programs); selected operational excellence + selected MLR (medical loss ratio) discipline; selected Medicare Advantage growth; selected operational reset.
• FY2026 thesis: Medicaid contract wins + Medicare Advantage growth + selected operational discipline + capital return — Molina selected aggressive Medicaid RFP win pace; selected Medicare Advantage continued growth + selected Marketplace; selected operational excellence drives selected operating margin sustainability. Key risks: Medicaid reimbursement (selected state-level rate pressure), contract retention (selected RFP renewal cycles), redetermination volume cycle (selected Medicaid membership volatility).

Company Background

Molina Healthcare Inc. (NYSE: MOH), founded 1980 by Dr. C. David Molina (selected as Long Beach California community physician serving low-income patients), is a large US managed care organization specializing in Medicaid + Medicare + Marketplace plans. Headquartered in Long Beach, California, Molina operates serving ~5.5M+ members across selected ~22 US states with selected market focus on government-sponsored health insurance programs. Molina's competitive moat rests on three structural advantages: (1) selected Medicaid managed care expertise — selected multi-decade focus on Medicaid managed care creates selected operational expertise + selected state regulatory relationships; (2) selected operational discipline + selected MLR management — selected medical loss ratio (MLR) management + selected provider network optimization + selected utilization management drive selected operating margin sustainability; (3) selected aggressive contract win strategy — selected RFP win track record (selected state Medicaid contract wins 2018-2024) demonstrates selected commercial execution.

CEO Joseph Zubretsky took CEO role November 2017 (succeeded John Molina + selected interim leadership amid 2017 family departures + selected operational reset). Zubretsky's background:

• The Hanover Insurance Group CEO (2013-2016)
• Aetna Senior Vice President + selected operational roles (2007-2013)
• Earlier insurance + selected executive ~25-year career

Zubretsky's tenure has executed:

• 2017-2018 Operational Reset: post-2017 Molina family departures + selected board-led operational reset; selected MLR discipline restored
• 2019-2021 Strong Cycle: selected Medicaid contract wins + selected Medicare Advantage growth + selected COVID-19 selected pandemic-period dynamics
• 2022-2025 Continued Growth: continued Medicaid RFP wins + selected acquisitions + selected operational discipline + selected redetermination cycle navigation

Zubretsky's strategic positioning emphasizes:

• Medicaid contract wins + selected RFP execution
• Medicare Advantage growth
• Selected operational excellence + MLR discipline
• Selected acquisitions (selected smaller selected)
• Selected capital return discipline (buybacks; no dividend)

Business Structure

Molina Healthcare reports operations across 3 segments by program type:

1. Medicaid — ~$28-30B FY2025 (~70% of revenue):

• Selected ~22 state Medicaid managed care contracts
• ~3.5-4M+ Medicaid members
• Selected state contracts: California + Texas + Washington + Ohio + selected Mississippi + Idaho + selected
• Selected long-term contract relationships + selected RFP renewal cycles
• Operating margin ~3-4% (typical Medicaid managed care; thin margins)
• Selected post-COVID redetermination cycle FY2023-2025 (selected Medicaid membership compression)

2. Medicare — ~$8-9B FY2025 (~20% of revenue):

• Medicare Advantage plans (~1M+ members)
• Selected Medicare Special Needs Plans (D-SNPs + selected)
• Operating margin ~5-7% (higher than Medicaid)
• Selected growth segment

3. Marketplace — ~$4-4.5B FY2025 (~10% of revenue):

• ACA Marketplace plans (~500K-700K members)
• Selected state-by-state coverage
• Operating margin ~2-4%
• Selected enrollment volatility tied to Marketplace + ACA dynamics

Key Core Metrics

Financial Performance Summary

Capital Return Framework (FY2025)

Market Evaluation

Molina Healthcare Inc. trades at ~14-17x forward earnings with no dividend yield, reflecting managed care valuation framework where investors price near-term Medicaid contract wins + Medicare Advantage growth + selected operational discipline + capital return into multiple. Bull case: continued Medicaid RFP wins + selected operational excellence + Medicare Advantage growth + selected capital return discipline; selected long-term Medicaid managed care secular growth. Bear case: Medicaid reimbursement (selected state-level rate pressure under selected administration), contract retention (selected RFP renewal cycle losses), redetermination volume cycle (selected Medicaid membership volatility extending).

Compared to peers: MOH vs Centene Corporation (CNC, larger Medicaid managed care ~$170B revenue + selected); MOH vs UnitedHealthcare Community + State (within UnitedHealth Group UNH); MOH vs Elevance Health (ELV, Anthem rebrand) Medicaid + selected; MOH vs Humana (HUM, Medicare Advantage focus + selected); MOH vs CVS Health Aetna Medicaid (within CVS); MOH vs selected smaller Medicaid managed care plans. Molina's selected Medicaid focus + selected operational discipline + selected RFP win track record create structural competitive advantages.

Medicaid Contract Wins + Medicare Advantage + Operational Discipline

The FY2026 thesis for Molina Healthcare Inc. centers on continued Medicaid contract wins + Medicare Advantage growth + selected operational discipline + capital return.

Medicaid Contract Wins:

• Selected aggressive RFP win track record 2018-2024
• Selected major state Medicaid contracts: California + Texas + Washington + Ohio + Mississippi + Idaho + selected
• Selected long-term contract relationships (~3-5 year typical contract terms with renewal options)
• FY2024-2025 selected continued RFP wins
• FY2026 expected: continued selected RFP win pace + selected new state market entries

Medicare Advantage Growth:

• ~1M+ Medicare Advantage members
• Selected Medicare Special Needs Plans (D-SNPs for dual-eligible; selected growth)
• FY2024-2025 +10-15% YoY Medicare revenue growth
• FY2026 expected: continued Medicare Advantage growth on selected enrollment

Operational Discipline + MLR Management:

• Medical loss ratio (MLR) ~88-89% FY2025 (selected disciplined; ~88% target Medicaid + 86% target Medicare + 85% target Marketplace)
• Selected provider network optimization + selected utilization management
• Selected administrative cost discipline
• FY2026 expected: continued MLR discipline + selected operating margin sustainability

Post-COVID Redetermination Cycle:

• COVID-era continuous Medicaid eligibility provisions ended April 2023
• Selected redetermination cycle FY2023-2025 created selected Medicaid membership compression
• Molina selected lost ~500K-700K members during redetermination
• FY2025 expected: redetermination cycle substantially complete; membership stabilizing
• FY2026 expected: continued membership recovery + selected new contract wins driving growth

Capital Return:

• No dividend (consistent with growth platform model + selected reserves)
• Buybacks $500M-1B FY2025 (~1-2%/yr share count reduction)
• Net debt minimal (selected MCO model with reserves)
• Investment-grade Ba2/BB+

FY2026 Outlook:

• Revenue toward $42-44B FY2026 (+5-7% on Medicaid contract wins + Medicare Advantage + Marketplace)
• Adj. EPS toward $23-25 (+5-10% on operational leverage + buyback compounding)
• MLR sustained 88-89%
• FCF $1.5-1.7B
• Capital return $500M-1B (buybacks)
• Diluted shares toward 55-56M
• FY2027 outlook: revenue $44-47B, adj. EPS $25-27, capital return $700M-1.2B

Key Risks:

• Medicaid reimbursement (selected state-level rate pressure under selected administration; selected MLR pressure if reimbursement insufficient for medical cost trends)
• Contract retention (selected RFP renewal cycles; selected major state contract losses possible)
• Redetermination volume cycle (selected Medicaid membership volatility extending)
• Selected Medicare Advantage rate pressure (selected CMS rate cuts)
• Selected Marketplace ACA enrollment volatility
• Selected medical cost trend pressure (selected GLP-1 + selected emerging therapies driving cost increases)
• Selected litigation + selected regulatory environment

FY2026 Watch Items:

• Medicaid contract wins + RFP outcomes
• Medicare Advantage membership growth
• MLR trajectory (target 88-89%)
• Adj. EPS growth (target +5-10%)
• Capital return execution
• Selected redetermination cycle completion
• Member growth metrics

Molina Healthcare Inc.'s FY2026 thesis is Medicaid contract wins + Medicare Advantage growth + operational discipline + capital return through managed care cycle. Validation: contract wins continue + Medicare Advantage grows + MLR sustained + buybacks delivered = thesis intact. Failure mode: Medicaid reimbursement severe + contract retention failures + redetermination cycle extending + medical cost trend severe = managed care cycle compression Molina cannot fully insulate against despite selected Medicaid focus + operational discipline.